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ABSTRACT
Objectives: This study examined sociodemographic,
smoking and psychosocial characteristics associated
with consent to participate in a smoking cessation trial
for socially disadvantaged smokers.
Design: Baseline data were collected prior to seeking
consent for the Call it Quits, a randomised controlled
trial.
Setting: An Australian social and community service
organisation. Sociodemographic, smoking and
psychosocial characteristics were compared between
smokers who agreed or declined to participate.
Participants: Of the 584 smokers invited to
participate, 431 (74%) consented and 153 (26%)
declined.
Results: Logistic regression modelling indicates the
ORs of participation were twice as high for those
reporting ‘high’ motivation to quit compared to the
‘moderate’ motivation group, and five times higher
than the ‘low’ motivation group (p=0.007). The ORs of
consenting were higher for those with a preference for
gradual reduction in cigarettes in quit attempts
compared with ‘no preference’. The ORs were lower for
those reporting ‘don’t know’ regarding their enjoyment
of smoking compared to ‘not at all’ enjoying smoking,
and reporting that fewer of their family or friends
smoked compared to ‘most or all’.
Conclusions: This study is the first to examine the
characteristics of socially disadvantaged smokers who
consent or decline to participate in a smoking
cessation trial. Low-income smokers who are
motivated to quit, are not enjoying smoking, had family
or friends who smoked, and who are interested in
gradual cessation approaches may be more likely to
participate in a smoking cessation trial.
Trial registration number: ISRCTN85202510.
INTRODUCTION
Smoking cessation for socially disadvantaged
groups is a public health priority in most
developed countries due to the
disproportionate disease burden attributable
to tobacco smoking among these groups.1 2
However, smoking cessation trials which have
attempted to target members of socially disad-
vantaged groups have usually achieved only
small sample sizes and low consent rates.3
Trials that draw samples from the general
population are rarely powered to adequately
examine outcomes according to social
group.3 As a result, knowledge of effective
ways to improve smoking cessation among
socially disadvantaged groups is lacking.
Generally in health and medical research,
groups from socioeconomically lower status
have been under-represented. A recent com-
prehensive systematic review of the barriers
Strengths and limitations of this study
▪ This is the first study to look at which disadvan-
taged individuals are more likely to participate in
a smoking cessation trial, reporting the demo-
graphics of individuals less likely to consent to
participate in a smoking cessation trial.
▪ We identified that low-income smokers who are
motivated to quit, are not enjoying smoking, had
family or friends who smoked, and are interested
in gradual cessation approaches may be more
likely to participate in a smoking cessation trial.
▪ A limitation of this paper is that it utilises a
two-step recruitment process which, while useful
in providing depth and breadth of information
about trial participants and non-participants,
excludes eligible individuals who were not inter-
ested or did not consent into the initial health
survey.
▪ A further study limitation is that external factors
not explored in this study, such as lack of time,
a high crisis situation for visiting the non-
government social and community service
organisation, and low literacy levels, may also
contribute to non-participation.
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to participation in medical research for disadvantaged
groups were numerous, including difﬁculties in identify-
ing and sampling the hidden populations, mistrust of
medical research and researcher, cultural or language
barriers, low literacy, and low education levels.3
To improve consent rates for trials targeting samples
from socially disadvantaged groups, it is important to
gain an understanding of the characteristics of indivi-
duals who are likely to consent to participate in trials
and those who are less able or willing to participate.
This information can help inform the development of
recruitment strategies for smoking cessation trials.
Few studies have compared the characteristics of
smoking cessation trial participants to non-participants
with smokers from socially disadvantaged groups.4 5 In
the USA, Warner et al5 described the factors associated
with eligible consenting smokers recruited from home-
lessness shelters returning for a randomisation appoint-
ment. The authors found that those who returned were
older and more likely to have a phone contact than eli-
gible participants who failed to return. This study is
limited, however, in that it only compared a small
number of factors affecting participation, and no data
were available on those smokers who declined participa-
tion at the consent stage.
This paper will describe consent rates for a sample of
socially disadvantaged smokers who were approached
to participate in an Australian trial—Call it Quits (CiQ)
—to increase cessation among a socially disadvantaged
group of smokers.6 In order to obtain a large sample of
smokers who experience high levels of multiple forms
of disadvantage including homelessness, unemploy-
ment, mental illness, substance abuse, and Indigenous
status, recruitment took place within a non-government
social and community service organisation (SCSO).
These services provide a range of counselling, material
(food and ﬁnancial), and emergency welfare aid to
people in need across Australia. Previous research has
shown that smoking prevalence is between 60% and
70% among the adult clients of SCSOs.7 A number of
evidence-based strategies were used to increase
response rates for the trial,3 including the offer of
smoking cessation support at no cost which included
an offer of free nicotine replacement therapy (NRT),
ﬁnancial reimbursement for time spent completing the
trial surveys, the use of simple, low reading age study
materials, and use of an engaging and acceptable com-
puterised health survey.3 8
The current study will examine the sociodemographic,
smoking, alcohol use and psychosocial characteristics
associated with consent to participate in the CiQ trial.
Data for this study were collected during a baseline
survey which was administered prior to seeking consent
for the trial, enabling participant and non-participant
characteristics to be compared. This provides new and
unique information on the differences between smokers
from socially disadvantaged groups who agree or decline
consent to participate in a smoking cessation trial.
METHODS
Study design
A self-administered cross-sectional survey was conducted
to assess eligibility for inclusion in a trial, to collect
health-related data, and to collect baseline trial data.
The CiQ trial, which has been described in detail else-
where,6 is a randomised controlled trial of a ﬁve-session
SCSO case-worker delivered smoking cessation interven-
tion for socially disadvantaged smokers.
Setting and sample
Study participants were recruited from a large SCSO in
regional NSW, Australia. Participants eligible for inclu-
sion in the baseline cross-sectional survey were SCSO
clients who were aged 18 years and above, sufﬁciently
ﬂuent in English, and well enough on the day of recruit-
ment to give informed consent and complete a survey.
SCSO clients who presented as agitated, distressed or
under the inﬂuence of alcohol or other drugs were ineli-
gible to participate. Individuals from socially disadvan-
taged groups are expected clients of these services,
including those who are Aboriginal Australians,
unemployed and living on government welfare, home-
less, with a mental illness or drug addiction, and young
single parents.9 Most SCSO clients report multiple forms
of disadvantage.
Procedures
A two-stage consent process was used where clients were
asked to: (1) consent to complete a general health
survey, and if they completed the survey and were identi-
ﬁed as eligible; (2) were asked to consent to participate
in a smoking cessation trial. Initially, all clients who pre-
sented for their SCSO appointment were informed by
staff that the service was involved in a university health
survey. SCSO staff asked eligible clients interested in par-
ticipating to present to the Research Assistant (RA) who
reassessed eligibility, provided the client with a partici-
pant information statement and sought written consent
to participate in a health survey. Those clients who com-
pleted the computer-administered health survey and
were identiﬁed during the survey as current tobacco
smokers, viewed a ﬁnal survey screen inviting participa-
tion in further research where they may receive a
service-based smoking cessation programme. The RA
provided willing clients with the CiQ trial participant
information statement and sought written consent for
participation in the trial.
All participants who completed the health survey
received a $20 grocery voucher, regardless of whether or
not they enrolled into the CiQ trial. During recruitment,
those participants who were eligible for the trial were
advised that they would receive a further $50 voucher at
each follow-up data collection period (1 and 6 months).
All study procedures were approved by the University of
Newcastle’s Human Research Ethics Committee
(H-2010-1002).
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Survey instrument
A 62-item computer survey was administered using Digivey
survey software.10 To assess eligibility for inclusion in the
smoking cessation trial, the following two items were used
to determine smoking status: (1) “Do you currently smoke
tobacco products?”, with the following response options
(A) “Yes, daily” (B)”Yes, at least once a week” (C) “Yes, but
less often than once a week” and (D) “No, not at all” and;
(2) “Have you smoked at least 100 cigarettes or a similar
amount of tobacco in your life?” with response options (A)
‘Yes’ (B) ‘No’ (C) ‘Not sure’. Current smokers were
deﬁned as self-reported daily or occasional smokers who
had smoked at least 100 cigarettes in their lifetime. Only
those participants who identiﬁed as current smokers were
invited to participate in this study.
Lifetime quit attempts were assessed by asking all partici-
pants, “Have you ever tried to quit smoking before (Yes/
No)?”11
Abrupt versus gradual cessation preference: Participants
were asked, “If you were thinking of quitting smoking,
would you prefer to stop suddenly or gradually cut down
on the number of cigarettes you smoke?” Response
options were (1) stop smoking suddenly, (2) gradually
cut down the number of cigarettes I smoked or (3) I
would not have a preference.12
Intentions to quit were assessed using the following ques-
tions: “What are your intentions regarding quitting? Do
you plan to: (1) Quit in the next 30 days, (2) Quit in the
next 6 months, (3) Quit, but not in the next 6 months,
(4) Never quit, or (5) Don’t know.”
Self-efﬁcacy was assessed by asking: “If you decided to
give up smoking completely in the next 6 months, how
sure are you that you would succeed?” Response options
were: (1) not at all sure, (2) slightly sure, (3) moderately
sure, (4) very sure or (5) extremely sure.11
Enjoyment of smoking was assessed by asking: “How
much do you enjoy smoking?” Response options were:
(1) very much, (2) quite a bit, (3) not particularly, (4)
not at all or (5) do not know.13
Smoker identity was assessed by asking: “Which of these
statements most applies to you?” Response options were:
(1) I hate being a smoker, (2) I am unhappy about
being a smoker, (3) I am happy about being a smoker,
or (4) do not know.14
Motivation to quit was measured on a 10-point Likert
scale: “On a scale of one to ten, please rate your current
motivation to give up smoking” (1=very low motivation,
10=very high motivation). Responses were collapsed into
the following categories: 1–3=low motivation, 4–6=mod-
erate motivation, and 7–10=high motivation and used as
a categorical measure.15
Nicotine dependence was measured using the two-item
Heaviness of Smoking Index (HSI).16 The Heaviness of
Smoking Index uses time after waking to ﬁrst cigarette
and number of cigarettes smoked per day to form an
index from zero to six, with higher scores indicating
higher levels of nicotine dependence (0–2=low depend-
ence, 3–4=moderate, 5–6=high).
Alcohol use: The Alcohol Use Disorders Identiﬁcation
Test—Short form (AUDIT-C) was used to measure
alcohol use.17 Scores of 4 or more for males (sensitiv-
ity=0.95, speciﬁcity 0.60)17 and 3 or more for females
(sensitivity: 0.66 Speciﬁcity 0.94)18 indicated risky
drinking.
Financial stress was assessed using the ﬁnancial stress
scale19 which uses a yes/no response scale to assess parti-
cipants’ experience of ﬁnancial stress in terms of eight
items of ﬁnancial or material deprivation, for example,
“being unable to heat home”. Scores on this scale range
from 0 to 8, with higher values indicating higher levels
of ﬁnancial stress.
Depression and anxiety: The Patient Health
Questionnaire—4 (PHQ4), an ultrabrief screening
measure for anxiety and depression, was used. This is a
composite measure of anxiety and depression within the
past 2 weeks. Higher scores indicate higher likelihood of
underlying depressive or anxiety disorder.20
Social contact was measured by using two questions,
“How often are you in contact with any member of your
family—including visits, phone calls, letters, or emails?”
and “How often are you in contact with any friends—
including visits, phone calls, letters, or emails?.”
Response options were (A) “Nearly every day” (B) “ 3–
4 days per week” (C) “1–2 days per week” (D) “1–3 days
per month” (E) “Less than once a month” (F) “Never”
(G) “No family/friends”.21
Resilience was measured using the Brief Resilience
Scale (BRS).22 The BRS comprises 6 items and concep-
tualises resilience as an individual’s way of “bouncing
back” after adversity.
Sociodemographic variables: Participants self-reported
their age, gender, highest level of education, marital
status, weekly net income level, type of housing, and
Aboriginal or Torres Strait Islander status.
Analyses
Sample size and power calculations for the CiQ trial are
available elsewhere.6 SAS V.9.3 (SAS Institute Inc., Cary,
North Carolina, USA) was used for all analyses.23
Descriptive statistics of sociodemographic (age, gender,
marital status, Aboriginal or Torres Strait Islander status,
education, housing type, income, income source) and
smoking (nicotine dependence, type of tobacco used,
previous quit attempt, preference for abrupt or gradual
cessation, quitting self-efﬁcacy, enjoyment of smoking,
smoker identity, friends or family who smoke, quit inten-
tions, and motivation to quit), alcohol consumption,
and mental health (depression, anxiety, resilience, social
contact, ﬁnancial stress) variables are presented as
numbers and percentages for categorical variables and
means (SD) or median (IQR) for continuous variables,
depending on distribution of the data.
Comparison of characteristics between consenter and
non-consenters was performed using the χ2 test for cat-
egorical variables, and independent t tests (parametric)
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or Mann-Whitney U tests (non-parametric) for continu-
ous variables.
Logistic regression was used to examine factors asso-
ciated with participant consent for the RCT. Variables
included in the model were selected based on clinical
and scientiﬁc knowledge prior to analysis of the data.
Multivariate model selection was performed to create the
ﬁnal adjusted model; variables were removed if these had
a p value >0.2 and were not of clinical signiﬁcance thus
ensuring that the inclusion or removal of each variable
did not grossly affect either the ﬁt of the model (LRT or
akaike information criterion (AIC)) or the estimates for
remaining variables. Within the multivariable model, col-
linearity was checked using variance inﬂation factors and
linearity assumption for continuous variables, and the
logit of the outcome were examined. Crude and adjusted
ORs with 95% CIs and Wald χ2 test p values will be pre-
sented for variables in the ﬁnal model.
RESULTS
Sample
Of the 906 participants who completed the baseline
questionnaire, 896 were screened for eligibility for the
smoking cessation trial; 584 (65%) were current smokers
and were invited to participate in the trial, of whom
431 (74%) consented and 153 (26%) declined to
participate. Table 1 shows the sociodemographic
characteristics, table 2 shows the psychosocial variables
and table 3 summarises the smoking-related character-
istics of those who did or did not consent to participate
in the CiQ trial.
Comparison of trial participants and non-participants
Participants and non-participants did not differ accord-
ing to sociodemographic (age, gender, education,
income amount and source, marital status, Indigenous
status and housing type) or psychosocial variables
(contact with family and friends, depression, anxiety,
resilience and ﬁnancial stress). A number of
smoking-related variables were signiﬁcantly associated
with consenting to the intervention trial (see table 3).
Results from the adjusted logistic regression model
(see table 4) showed a number of factors made independ-
ent contributions to the OR of consenting to participate
in the trial. The OR of participation were twice as high
for those reporting ‘high’motivation to quit compared to
the ‘moderate’ motivation group, and ﬁve times higher
than the ‘low’ motivation group (p=0.0007). The ORs of
consenting were also twice higher for those with a prefer-
ence for gradual reduction in cigarettes in quit attempts
compared with ‘no preference’ (OR=2.1, 95% CI 1 to
4.1). The ORs were lower for those reporting ‘don’t
know’ regarding their enjoyment of smoking compared
Table 1 Sociodemographic characteristics of smoking cessation trial participants and non-participants (n=584)
Participation n (%)
p Value*Yes No Total
Age
Mean (SD) years 38 (11) 39 (10) 77 (11) 0.29
Gender
Female 210 (49) 81 (47) 291 (50) 0.37
Male 221 (51) 72 (53) 293 (50)
Education
Up to primary school 82 (19) 33 (22) 115 (20)
Secondary school 237 (55) 91 (59) 328 (56)
Tertiary qualifications 112 (26) 29 (19) 141 (24) 0.21
Marital status
Married or living with partner 53 (12) 22 (14) 75 (13)
Separated/divorced/widowed 143 (33) 52 (34) 195 (34)
Never married 235 (55) 79 (52) 314 (54) 0.81
Housing type
Own house 13 (3) 5 (3) 18 (3)
Rental house 128 (30) 44 (29) 172 (29)
No home/hotel, motel, with family or friends, street living, other 84 (19) 22 (14) 106 (18)
Government housing or supported accommodation 206 (48) 82 (54) 288 (49) 0.65
Income amount
<$200 per week 115 (28) 42 (28) 157 (28)
$201–$400 per week 234 (58) 77 (51) 311 (56)
>$400 per week 55 (14) 31 (21) 86 (16) 0.11
Income source
Paid employment (full or part time) or other (eg, friends or family) 25 (6) 8 (6) 33 (6)
Government benefits 406 (94) 145 (26) 551 (94) 0.28
Aboriginal or Torres Strait Islander 74 (17) 17 (11) 91 (16) 0.08
*χ2 Tests for categorical variables, and independent t tests for continuous variables (age).
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to ‘not at all’ enjoying smoking (OR=0.3, 95% CI 0.9 to
0.8), and reporting that ‘about half’ (OR=0.5; 95% CI 0.3
to 0.9) or ‘a few/less than half’ (OR=0.6; 95% CI 0.3 to
1)) of their friends or family smoked lowered the OR of
participating than reporting that ‘most or all’ of their
family or friends smoked.
DISCUSSION
This study is the ﬁrst study to examine the characteristics
that distinguish socially disadvantaged smokers who
consent to participate in a smoking cessation trial from
those who do not. A large range of personal character-
istics were examined and a number of these differen-
tiated the participants in the trial from non-participants.
Lower enjoyment of smoking, higher motivation to quit
smoking, preference for gradual reduction approach for
cessation, and high numbers of family and friends who
smoke were associated with consent into a smoking cessa-
tion trial for a sample of socially disadvantaged smokers.
The extent of socioeconomic disadvantage experi-
enced by the sample is worth noting. The sample con-
sisted of adults with high rates of homelessness, anxiety
and depression, alcohol abuse, self-identiﬁcation as
Aboriginal or Torres Strait Islander peoples and low edu-
cation attainment. The sample displayed exceptionally
low income with 84% reporting income well below the
Australian single-person ‘poverty line’ of $500 per
week,24 and 94% dependent on government beneﬁts as
their main source of income. The high consent rate
(74%) from those eligible to enter the trial may be due
to interest in seeking assistance to quit smoking, that is,
the offer, made during recruitment, of free NRT if ran-
domised to the intervention group, as well as ﬁnancial
reimbursements for their time. Notwithstanding the
socioeconomic disadvantage of the clients in the
sample, these incentives may be particularly attractive to
individuals under ﬁnancial strain.25
It is important to identify those factors which might
motivate socially disadvantaged smokers to participate in
smoking cessation trials. Some factors associated with
intrinsic motivation to quit were found to differentiate
participants from non-participants. Enjoyment of
smoking was found to be associated with participation
whereby those who reported ambivalence or uncertainty
regarding their enjoyment of smoking had lower odds of
participation relative to those reporting not enjoying
smoking. As expected, higher rating of motivation to stop
smoking was associated with greater odds of participation
in the cessation trial. There is a need to increase interest
in participating in smoking cessation research among
smokers who may not be motivated to quit smoking.13
Use of motivational interviewing techniques during
recruitment warrants further consideration. There were
also greater odds of participation in the trial for those
preferring an approach to quitting that allowed a gradual
reduction in smoking, relative to no preference. Reduce
to quit approaches have been found to be effective for
cessation.26 There may be a need to offer a ‘reduce to
quit’ approach which is likely to attract smokers from
Table 2 Alcohol use and psychosocial characteristics of smoking cessation trial participants and non-participants (n=584)
Participation n (%)
p Value*Yes No Total
Alcohol use
No use 108 (25) 40 (26) 148 (26)
Non-risky use 65 (15) 22 (14) 87 (15)
Risky use 252 (59) 90 (59) 342 (59) 0.96
Contact with family
Never or no family 68 (16) 22 (14) 90 (15)
1–3 days a month/less than once a month 118 (27) 40 (26) 158 (27)
1–2 days a week 90 (21) 25 (16) 115 (20)
Nearly every day/3–4 days a week 155 (36) 66 (43) 221 (38) 0.40
Contact with friends
Never or no friends 75 (17) 23 (15) 98 (17)
1–3 days a month/less than once a month 88 (20) 27 (18) 115 (20)
1–2 days a week 86 (20) 31 (20) 117 (20)
Nearly every day/3–4 days a week 182 (42) 72 (47) 254 (43) 0.71
Financial stress score
Mean (SD) 5.7 (1.7) 5.8 (1.7) 5.7 (1.7) 0.35
Depression
Median (minimum, maximum) 12 (0.27) 11 (0.27) 12 (0.27) 0.99
Anxiety
Median (minimum, maximum) 3 (0.6) 4 (0.6) 3 (0.6) 0.93
Resilience
Median (minimum, maximum) 2.8 (1.5) 3 (1.5) 3 (1.5) 0.11
*χ2 Tests for categorical variables, independent t tests for comparison of means (financial stress), and Mann Whitney U tests for comparison
of medians (depression, anxiety and resilience).
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socially disadvantaged groups to cessation trials. Having
higher numbers of family and friends who smoke was a
surprising association with consent to participate. Socially
disadvantaged smokers report low social support to quit
smoking and being embedded in a social network and
context of smoking.27 Perhaps for these smokers, the
offer of possibly receiving a smoking cessation pro-
gramme was an opportunity to gain some assistance in
their attempts to quit smoking.
The current results may also aid stop smoking services
develop strategies for attracting socially disadvantaged
smokers. Some studies have examined the characteristics
Table 3 Smoking-related characteristics of smoking cessation trial participants and non-participants (n=584)
Participation n (%)
p Value*Yes No Total
Age started smoking
Mean (SD) years 15 (4) 15 (5) 15 (4) 0.57
Nicotine dependence (HSI)
Low 130 (34) 42 (32) 172 (33)
Moderate 194 (51) 68 (52) 262 (51)
High 60 (16) 21 (16) 81 (16) 0.93
Tobacco type smoked
Pre-rolled cigarettes 249 (58) 85 (56) 334 (57)
Roll your own cigarettes 173 (40) 65 (42) 238 (41)
Chop chop (low grade loose leaf) 9 (2) 3 (2) 12 (2) 0.88
Smoker identity
I hate being a smoker 149 (35) 44 (29) 193 (33)
I am unhappy about being a smoker 176 (41) 62 (41) 238 (41)
I am happy about being a smoker 26 (6) 12 (8) 38 (7)
Do not know 80 (19) 35 (23) 115 (20) 0.43
Enjoyment of smoking
Not at all 54 (13) 9 (6) 63 (11)
Not particularly 141 (33) 53 (35) 194 (33)
Quite a bit 138 (32) 38 (25) 176 (30)
Very much 57 (14) 32 (21) 89 (15)
Do not know 40 (9) 21 (14) 61 (10) 0.01
Friends or family who smoke
None 35 (8) 14 (9) 49 (8)
A few or less than half 122 (28) 52 (34) 174 (30)
About half 104 (24) 42 (27) 146 (25)
Most or all of them 170 (39) 45 (29) 215 (37) 0.18
Quit attempts ever
Yes 362 (84) 125 (82) 487 (83) 0.51
Quit attempt approach preference
Stop smoking suddenly 131 (30) 57 (37) 188 (32)
Gradual reduction of cigarettes 261 (61) 74 (48) 335 (58)
No preference 39 (9) 22 (14) 61 (10) 0.02
Quit self-efficacy
Not at all sure 138 (32) 52 (34) 190 (33)
Slightly sure 87 (20) 27 (18) 114 (20)
Moderately sure 110 (26) 40 (26) 150 (26)
Very sure 52 (12) 22 (14) 74 (13)
Extremely sure 44 (10) 12 (8) 56 (10) 0.80
Quit intention
Quit in the next 30 days 83 (19) 15 (10) 98 (17)
Quit in the next 6 months 121 (28) 44 (29) 165 (28)
Quit, but not in next 6 months 60 (14) 18 (12) 78 (13)
Never want to quit 14 (3) 10 (7) 24 (4)
Do not know 153 (35) 66 (43) 219 (38) 0.03
Motivation to quit
High 162 (38) 37 (24) 199 (34)
Moderate 181 (42) 65 (43) 244 (42)
Low 85 (20) 50 (33) 135 (23) <0.001
*χ2 Tests for categorical variables and independent t tests for continuous variables (age started smoking).
HSI, Heaviness of Smoking Index.
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of smokers attending smoking cessation clinics.28 29
Using largely observational data, these studies have
found that the UK-based stop smoking services have
been successful at attracting smokers from socio-
economically disadvantaged areas28 and that this has
translated into increased abstinence rates for 1 year.
Table 4 Logistic regression models of participant factors* associated with participation in the smoking cessation trial (n=584)
Unadjusted
OR (95% CI) p Value
Adjusted
OR (95% CI) p Value
Age in years (continuous) 0.99 (0.9 to 1.0) 0.29 0.99 (0.9 to 1.0) 0.29
Gender
Male Ref – –
Female 0.85 (0.6 to 1.2) 0.37 0.63 (0.4 to 1.0) 0.05
Indigenous status
Non-Aboriginal Ref –
Aboriginal or Torres Strait Islander 1.66 (0.9 to 2.9) 0.07 2.05 (1.0 to 4.1) 0.05
Income 0.11 0.08
> $400 per week Ref – –
$201–$400 per week 1.71 (1.0 to 2.0) 1.94 (1.0 to 4.0)
<$200 per week 1.54 (0.9 to 2.7) 1.43 (0.7 to 3)
Anxiety score (continuous) 0.99 (0.9 to 1.1) 0.86 0.96 (0.8 to 1.1) 0.59
Depression score (continuous) 1.0 (0.9 to 1.0) 0.99 0.99 (0.9 to 1.0) 0.73
Financial stress score (continuous) 0.96 (0.9 to 1.1) 0.41 0.89 (0.8 to 1.0) 0.11
Resilience score (continuous) 0.82 (0.6 to 1.1) 0.10 0.77 (0.6 to 1.0) 0.11
Heaviness of smoking index 0.93 0.63
Low Ref – –
Moderate 0.92 (0.6 to 1.4) 0.78 (0.5 to 1.3)
High 0.92 (0.4 to 1.7) 0.86 (0.4 to 1.8)
Enjoyment of smoking 0.01 0.02
Not at all Ref – –
Not particularly 0.44 (0.2 to 0.9) 0.44 (0.2 to 1.2)
Quite a bit 0.61 (0.3 to 1.3) 0.79 (0.3 to 2.2)
Very much 0.30 (0.1 to 0.7) 0.42 (0.1 to 1.3)
Do not know 0.32 (0.1 to 0.8) 0.27 (0.1 to 0.8)
Friends or family who smoke 0.17 0.12
Most or all of them Ref – –
About half 0.66 (0.4 to 1.1) 0.54 (0.3 to 0.9)
A few/less than half 0.62 (0.4 to 0.9) 0.56 (0.3 to 1.0)
None 0.66 (0.3 to 1.3) 0.87 (0.4 to 2.1)
Quit attempt ever
Yes Ref – –
No 0.85 (0.5 to 1.4) 0.51 1.06 (0.6 to 1.9) 0.85
Quit self-efficacy 0.79 0.59
Not at all sure Ref – –
Slightly sure 1.21 (0.7 to 2.1) 0.79 (0.4 to 1.5)
Moderately sure 1.04 (0.6 to 1.7) 0.79 (0.4 to 1.5)
Very sure 0.89 (0.5 to 1.6) 0.51 (0.2 to 1.1)
Extremely sure 1.38 (0.7 to 2.8) 0.79 (0.3 to 2.0)
Quit attempt approach preference 0.02 0.08
No preference Ref – –
Gradual reduction of cigarettes 1.99 (1.1 to 3.6) 2.07 (1.0 to 4.2)
Stop smoking suddenly 1.29 (0.7 to 2.4) 1.43 (0.7 to 3.0)
Motivation to quit <0.01 <0.01
High Ref – –
Moderate 0.62 (0.4 to 1.0) 0.50 (0.3 to 0.9)
Low 0.39 (0.2 to 0.6) 0.26 (0.1 to 0.5)
Alcohol use 0.95 0.81
No use Ref – –
Non-risky use 1.09 (0.6 to 2.0) 1.11 (0.5 to 2.3)
Risky use 1.04 (0.7 to 1.6) 1.19 (0.7 to 2.0)
*Only those variables entered into the logistic regression shown.
p Values from Wald χ2 test.
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Study limitations
There are a number of study limitations which should
be considered. The two-stage recruitment process, while
useful in providing depth and breadth of information
about trial participants and non-participants, excluded
eligible individuals who were not interested or did not
consent to the initial health survey. There is low prob-
ability of systematic biases during recruitment given that
the consent rate in the health survey was high (96%)
among those who did approach the RA, and attempts
were made to ensure that at this stage no reference to
the smoking cessation trial was made by describing the
survey as a ‘general health survey’, ensuring that
smokers were just as likely as non-smokers to participate.
However, we do not know how many clients were not
referred to the RA and did not approach the RA.
Although staff was asked to refer all eligible clients to
the RA, there is the possibility that some were missed or
that some clients did not approach the RA. A further
study limitation is that external factors not explored in
this study, such as lack of time, a high crisis situation for
visiting the SCSO and low literacy levels, may also con-
tribute to non-participation.
In conclusion, based on current results, it would appear
important that smoking cessation trials that aim to recruit
socially disadvantaged smokers incorporate recruitment
strategies that provide extrinsic and intrinsic motivational
techniques such as ﬁnancial reimbursements; use of
known and acceptable settings, for example, the SCSO ser-
vices; intervention components, including NRT at no cost;
offers of ‘reduce to quit’ strategies; and motivational inter-
viewing components. Given the increasing urgency for
conducting methodologically sound smoking cessation
trials for smokers from socially disadvantaged groups, the
results of this study are pertinent.
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